An educated patient has the best chance of success with therapy. He or she should ultimately decide for him or herself if they believe they can benefit from ketamine infusion therapy.
Current clinical trials:
Double Blind, Active, University of Ottawa
Double Blind, Active, Columbia University
Double Blind, Completed, Icahn School of Medicine at Mount Sinai
Open Label, Completed, Yale University